Adding Rivaroxaban to aspirin therapy resulted in 1% fewer composite cardiovascular outcomes, but cause a 1% increase in bleeds. Andrew and Joe conclude that Rivaroxaban does not offer benefits above aspirin alone in the study population.

Andrew Buelt, DO • Joe Weatherly, DO